The Commercial Trajectory of Disease-Modifying Therapies (DMTs):...

adicionou um novo artigo Outro

2026-03-18 09:26:03 - Traduzir -

The Commercial Trajectory of Disease-Modifying Therapies (DMTs): Analyzing the Market Impact of Amyloid-Beta and Tau-Targeting Monoclonal Antibodies (2025–2032)

As the global population ages and neurodegenerative research reaches a critical inflection point, the landscape for cognitive healthcare is expanding at an unprecedented rate. According to the latest market intelligence, the global Dementia and Alzheimer’s Disease Market, which was valued at USD 13,000.00 million in 2022, is undergoing a period of rapid evolution. Driven...

0 Comentários 0 Compartilhamentos 842 Visualizações 0 Anterior